No Cover Image

Journal article 182 views

Targeting NRF2 and FSP1 to Overcome Ferroptosis Resistance in TSC2-Deficient and Cancer Cells

Tasmia Tahsin, Darius K. McPhail Orcid Logo, Jesse D. Champion, Mohammad A. M. Alzahrani, Madeleine L. Hilditch, Alexandre Faris-Orr, Brian L. Calver, James Cronin Orcid Logo, Juan C. Mareque-Rivas, Darren W. Sexton Orcid Logo, Stephen Fôn Hughes Orcid Logo, Steve Conlan Orcid Logo, David Mark Davies, Andrew R. Tee Orcid Logo

Cancers, Volume: 17, Issue: 16, Start page: 2714

Swansea University Authors: James Cronin Orcid Logo, Steve Conlan Orcid Logo

Full text not available from this repository: check for access using links below.

Check full text

DOI (Published version): 10.3390/cancers17162714

Published in: Cancers
ISSN: 2072-6694
Published: MDPI AG
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa70650
first_indexed 2025-10-13T16:14:26Z
last_indexed 2025-10-14T10:08:25Z
id cronfa70650
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2025-10-13T17:14:23.8028811</datestamp><bib-version>v2</bib-version><id>70650</id><entry>2025-10-13</entry><title>Targeting NRF2 and FSP1 to Overcome Ferroptosis Resistance in TSC2-Deficient and Cancer Cells</title><swanseaauthors><author><sid>9cfd17551c0d1f7438895121e4fbb6e8</sid><ORCID>0000-0002-0590-9462</ORCID><firstname>James</firstname><surname>Cronin</surname><name>James Cronin</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>0bb6bd247e32fb4249de62c0013b51cb</sid><ORCID>0000-0002-2562-3461</ORCID><firstname>Steve</firstname><surname>Conlan</surname><name>Steve Conlan</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2025-10-13</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Cancers</journal><volume>17</volume><journalNumber>16</journalNumber><paginationStart>2714</paginationStart><paginationEnd/><publisher>MDPI AG</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic>2072-6694</issnElectronic><keywords/><publishedDay>0</publishedDay><publishedMonth>0</publishedMonth><publishedYear>0</publishedYear><publishedDate>0001-01-01</publishedDate><doi>10.3390/cancers17162714</doi><url>https://doi.org/10.3390/cancers17162714</url><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2025-10-13T17:14:23.8028811</lastEdited><Created>2025-10-13T17:12:38.0168453</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Biomedical Science</level></path><authors><author><firstname>Tasmia</firstname><surname>Tahsin</surname><order>1</order></author><author><firstname>Darius K.</firstname><surname>McPhail</surname><orcid>0009-0006-4490-2972</orcid><order>2</order></author><author><firstname>Jesse D.</firstname><surname>Champion</surname><order>3</order></author><author><firstname>Mohammad A. M.</firstname><surname>Alzahrani</surname><order>4</order></author><author><firstname>Madeleine L.</firstname><surname>Hilditch</surname><order>5</order></author><author><firstname>Alexandre</firstname><surname>Faris-Orr</surname><order>6</order></author><author><firstname>Brian L.</firstname><surname>Calver</surname><order>7</order></author><author><firstname>James</firstname><surname>Cronin</surname><orcid>0000-0002-0590-9462</orcid><order>8</order></author><author><firstname>Juan C.</firstname><surname>Mareque-Rivas</surname><order>9</order></author><author><firstname>Darren W.</firstname><surname>Sexton</surname><orcid>0000-0003-3344-3150</orcid><order>10</order></author><author><firstname>Stephen F&#xF4;n</firstname><surname>Hughes</surname><orcid>0000-0001-6558-9037</orcid><order>11</order></author><author><firstname>Steve</firstname><surname>Conlan</surname><orcid>0000-0002-2562-3461</orcid><order>12</order></author><author><firstname>David Mark</firstname><surname>Davies</surname><order>13</order></author><author><firstname>Andrew R.</firstname><surname>Tee</surname><orcid>0000-0002-5577-4631</orcid><order>14</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2025-10-13T17:14:23.8028811 v2 70650 2025-10-13 Targeting NRF2 and FSP1 to Overcome Ferroptosis Resistance in TSC2-Deficient and Cancer Cells 9cfd17551c0d1f7438895121e4fbb6e8 0000-0002-0590-9462 James Cronin James Cronin true false 0bb6bd247e32fb4249de62c0013b51cb 0000-0002-2562-3461 Steve Conlan Steve Conlan true false 2025-10-13 MEDS Journal Article Cancers 17 16 2714 MDPI AG 2072-6694 0 0 0 0001-01-01 10.3390/cancers17162714 https://doi.org/10.3390/cancers17162714 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2025-10-13T17:14:23.8028811 2025-10-13T17:12:38.0168453 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Biomedical Science Tasmia Tahsin 1 Darius K. McPhail 0009-0006-4490-2972 2 Jesse D. Champion 3 Mohammad A. M. Alzahrani 4 Madeleine L. Hilditch 5 Alexandre Faris-Orr 6 Brian L. Calver 7 James Cronin 0000-0002-0590-9462 8 Juan C. Mareque-Rivas 9 Darren W. Sexton 0000-0003-3344-3150 10 Stephen Fôn Hughes 0000-0001-6558-9037 11 Steve Conlan 0000-0002-2562-3461 12 David Mark Davies 13 Andrew R. Tee 0000-0002-5577-4631 14
title Targeting NRF2 and FSP1 to Overcome Ferroptosis Resistance in TSC2-Deficient and Cancer Cells
spellingShingle Targeting NRF2 and FSP1 to Overcome Ferroptosis Resistance in TSC2-Deficient and Cancer Cells
James Cronin
Steve Conlan
title_short Targeting NRF2 and FSP1 to Overcome Ferroptosis Resistance in TSC2-Deficient and Cancer Cells
title_full Targeting NRF2 and FSP1 to Overcome Ferroptosis Resistance in TSC2-Deficient and Cancer Cells
title_fullStr Targeting NRF2 and FSP1 to Overcome Ferroptosis Resistance in TSC2-Deficient and Cancer Cells
title_full_unstemmed Targeting NRF2 and FSP1 to Overcome Ferroptosis Resistance in TSC2-Deficient and Cancer Cells
title_sort Targeting NRF2 and FSP1 to Overcome Ferroptosis Resistance in TSC2-Deficient and Cancer Cells
author_id_str_mv 9cfd17551c0d1f7438895121e4fbb6e8
0bb6bd247e32fb4249de62c0013b51cb
author_id_fullname_str_mv 9cfd17551c0d1f7438895121e4fbb6e8_***_James Cronin
0bb6bd247e32fb4249de62c0013b51cb_***_Steve Conlan
author James Cronin
Steve Conlan
author2 Tasmia Tahsin
Darius K. McPhail
Jesse D. Champion
Mohammad A. M. Alzahrani
Madeleine L. Hilditch
Alexandre Faris-Orr
Brian L. Calver
James Cronin
Juan C. Mareque-Rivas
Darren W. Sexton
Stephen Fôn Hughes
Steve Conlan
David Mark Davies
Andrew R. Tee
format Journal article
container_title Cancers
container_volume 17
container_issue 16
container_start_page 2714
institution Swansea University
issn 2072-6694
doi_str_mv 10.3390/cancers17162714
publisher MDPI AG
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Biomedical Science{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Biomedical Science
url https://doi.org/10.3390/cancers17162714
document_store_str 0
active_str 0
published_date 0001-01-01T05:31:21Z
_version_ 1851098064343793664
score 11.089386

Similar Items